Effect of an alkyl spacer on the morphology and internalization of MUC1 aptamer‐naphthalimide amphiphiles for targeting and imaging triple negative breast cancer cells-Reference-Cited by-同舟云学术

Effect of an alkyl spacer on the morphology and internalization of MUC1 aptamer‐naphthalimide amphiphiles for targeting and imaging triple negative breast cancer cells

Published:2020-11-10 Issue:1 Volume:6 Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioeng Transl Med

Author:

Kuang Huihui¹,Schneiderman Zachary¹²,Shabana Ahmed M.¹³,Russo Gabriella C.¹²,Guo Jun¹,Wirtz Denis¹²,Kokkoli Efrosini¹²^ORCID

Affiliation:

1. Institute for NanoBioTechnology Johns Hopkins University Baltimore Maryland USA

2. Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USA

3. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy Cairo University Cairo Egypt

Funder

Johns Hopkins University

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10194

Reference51 articles.

1. Recent advances in nanotheranostics for triple negative breast cancer treatment

2. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

3. Triple-Negative Breast Cancer

4. Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel

5. Peptide density targets and impedes triple negative breast cancer metastasis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10

2. Formation of ssDNA nanotubes from spherical micelles and their use as a delivery vehicle for chemotherapeutics and senolytics to triple negative breast cancer cells;Nanoscale;2023

3. Relevance of aptamers as targeting ligands for anticancer therapies;Aptamers Engineered Nanocarriers for Cancer Therapy;2023

4. MUC1: An emerging target in cancer treatment and diagnosis;Bulletin du Cancer;2022-11

5. Multivalent Aptamer Approach: Designs, Strategies, and Applications;Micromachines;2022-03-12